Sapporo, Japan

Nayuta Shimizu

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hokkaido University, Nof Corporation. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nayuta Shimizu. Retrieved from https://idiyas.com/inventor/nayuta-shimizu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nayuta Shimizu: Innovator in Nucleic Acid Delivery

Introduction

Nayuta Shimizu is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. His innovative work focuses on enhancing the efficiency of intracellular delivery mechanisms.

Latest Patents

Nayuta Shimizu holds a patent for a cationic lipid designed for nucleic acid delivery. This invention provides a cationic lipid capable of achieving higher intracellular delivery efficiency than conventional cationic lipids. It serves as a lipid membrane structure that acts as a carrier for delivering functional nucleic acids. The cationic lipid is represented by the formula (1).

Career Highlights

Throughout his career, Nayuta Shimizu has worked with notable organizations, including Nof Corporation and Hokkaido University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of biotechnology.

Collaborations

Nayuta has collaborated with talented individuals such as Shota Sasaki and Masaki Ota. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Nayuta Shimizu is a key figure in the innovation of nucleic acid delivery systems. His work continues to influence the field of biotechnology, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…